recB and recC strains of Escherichia coli K12 are recombination deficient and sensitive to ultraviolet light and the drug, mitomycin C. We have reported that sbcB mutations indirectly suppress all three phenotypes and result in the loss of exonuclease I. In this publication we report the occurrence of other mutations that lead to loss of exonuclease I and indirectly suppress mitomycin and UV sensitivity but not recombination deficiency. These mutations (called xonA) are cotransducible with his and closely linked with sbcB. Both sbcB and xonA mutant strains appear to have identical residual amounts of nuclease activity on single-stranded DNA. It is hypothesized that exonuclease I possesses' a second activity other than its known ability to degrade single-stranded DNA from a 3'-OH terminus. Accordingly, sbcB mutations would alter the second activity while xonA mutations would not. resulting from the presence of recB and recC mutations; however, the inability to perform genetic recombination remains unaffected. Such mutations are called xonA -because they also result in the loss of exonuclease I activity. The xonA locus cotransduces with his and is closely linked with sbcB. It is not clear at present whether xonA -and sbcB represent mutations in independent, but closely linked, genes or mutations in the same gene. Regardless, it may be that exonuclease I has an activity other than its known (5) 3'-'o5' action on singlestranded DNA.
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The presence of recB and recC mutationst in Escherichia coli leads to a 100-to 200-fold decrease in genetic recombination as well as to an increased sensitivity to ultraviolet light (UV) and the drug mitomycin C (1, 2). Barbour et al. (3) showed that such mutations could be indirectly suppressed by sbcA mutations. Kushner et al. (4) found recB and recC mutations could also be indirectly suppressed by sbcB mutations, distinguishable from the unmapped sbcA mutations by their cotransducibility with his. In all sbcB-mutants studied the return of wild-type levels of genetic recombination and UV and mitomycin resistance was accompanied by the loss of exonuclease I (4). It was suggested that sbcB was, in fact, the structural gene for exonuclease I. Genetic and enzymatic studies on strains carrying deletions in the his region tended to confirm this hypothesis (Templin, A., Kushner Taylor (9) with the exception of sbc, which stands for a set of genes involved in the indirect suppression of recB2l or recC22, and xonA, which stands for a gene involved in the production of exonuclease I. Phenotypic abbreviations are as follows: Rec, recombination; UV, ultraviolet irradiation; Mit, mitomycin; -(minus), requiring when used with abbreviations of amino acids, and deficient when used with Rec; + (plus), independence when used with abbreviations of amino acids and proficient when used with Rec; R, resistance; S, sensitivity.
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MATERIALS AND METHODS
The experiments described were mostly performed with revertants and transductants of derivatives of AB1157, a multiply marked auxotrophic strain of E. coli K12. BW7 and BW46 were of a different genetic background and were generously provided by Dr. Bernard Weiss. Both were prototrophs and were sensitive to mitomycin C due to a mtcmutation similar to that described by Otsuji (6) . In addition, BW46 is a derivative of BW7, deficient in exonuclease I, isolated by the method of Milcarek and Weiss (7) .
Reagents (10) . Scintillation fluid was made according to a formula listed by Clark et al. (11) .
The procedures and media for conjugational and transductional crosses and for the discrimination of Rec from Rec+ strains have been described (12) (13) (14) . All revertant strains were checked for the recB-recC ATP-dependent nuclease by the assay of Barbour et al. (15) . Mitomycin-resistant revertants of Rec-mutants were selected by the method of Barbour et al. (3) , except that the mitomycin concentration was 1 ,g/ml.
Ultraviolet irradiation was done with a calibrated 15 W G.E. germicidal lamp (12) . We determined resistance to mitomycin by spreading cells from an L broth culture in stationary phase directly onto I-agar plates containing the concentrations of the drug indicated and then incubating to allow survivors to form colonies.
For quantitative enzymatic determinations strains were grown in EM9 as described (4) . Exonuclease I activity was determined by growth of the strains in 10 ml of L broth in an overnight standing culture. The cells were collected by cen-rec-Suppression by EXQ I Deficiency trifugation and lysed immediately by the Brij-lysis procedure as outlined by Barbour et al. (3) . Exonuclease I was assayed as described (4) . One unit of exonuclease I is defined as that amount of protein that catalyzes the release of 1.0 nmol of nucleotide from heat-denatured DNA in 30 min at 37°. Protein concentrations were determined by the method of Lowry etal. (16) .
RESULTS
Mutant strains lacking exonuclease I had heretofore been obtained as mitomycin-resistant revertants from recB-recCand recB+ recC-strains of E. coli (4) . In addition to becoming MitR, these strains had also become resistant to UV (UVR) and recombination proficient (Rec+). They retained their original recB and recC mutations and, in addition, acquired a suppressor mutation termed sbcB-. Since all of these sbcB mutants had lost exonuclease I, it was hypothesized that any exonuclease I deficiency mutation would suppress recB and recC mutations and lead to a Rec+, MitR, and UVR phenotype in a recB-recC-strain. A strain deficient in exonuclease I which was isolated by screening several thousand survivors of a heavily mutagenized population of wild-type E. coli cells for the loss of enzymatic activity, was graciously provided by Dr. Bernard Weiss. The mutation in this strain was Table 2 and Fig. 1 (Fig. 1A and B) , and none of the three had regained normal levels of exonuclease I (Table 2) . Hence, in the presence of xonAl the mitomycin and UV sensitivity conferred by the recB-and recC-mutations was indirectly suppressed, apparently through the loss of exonuclease I activity; however, the loss of this activity (i.e., the ability to degrade singlestranded DNA in the 3'-'o5' direction) did not suppress the Rec phenotype of recB and recC cells.
Attempts were made to isolate directly strains similar to JC8218 by treatment of JC7645, a his+ derivative of a recB21 recC22 double mutant, with nitrosoguanidine and plating the survivors on agar plates containing mitomycin. 5% of the colonies were still Mit6, 15% exhibited the xonA phenotype (i.e., were MitRUVRRecj), and 80% were of the sbcB-variety (i.e., were MitRUVRRec+). In Table 3 are listed the characteristics of several of the independently isolated MitRUVRxonA strains. All these mutants had lost exonuclease I activity but remained phenotypically Rec-, although recombination frequencies 5-to 13-fold higher than that of the parent, JC7645, were noted. When two of these mutants, JC8262 and JC8265, were used as P1 transductional donors and JC7623 was used as recipient, the xonA mutations were found to be 71.9 and 77.3% cotransducible with his+, respectively. Derivatives of JC8262 and JC8265 inheriting F30 (Fhis-832 xonA + sbcB+) became UV" and Mit5 and regained exonuclease I. The properties of two such heterozygotes, JC8289 and JC8292, are listed in Table 4 .
These findings indicated that there might be two genes in- Proc.'Nat. Acad. Sci. USA 69 (1972) volved in the production of exonuclease I: xonA and sbcB. In addition, they indicated that the sbcB mutant characterized enzymatically in this laboratory (4) might, in fact, be a double mutant carrying both a xonA mutation to suppress the Mit8 and UV" phenotypes and an sbcB mutation to suppress the Rec-phenotype of the recB-recC-mutations. To test this hypothesis, a P1 transductional cross was performed in which the sbcBl5 mutant, JC7623, was the recipient and the his+-xonA+sbcB+ strain, BW7, was the donor. His+ transductants were screened for the xonA-sbcB+ phenotype (i.e., MitRUVRRecj) and the hypothetical true xonA + sbcBphenotype (i.e., Mit8UV8Rec+). If JC7623 were in fact a double mutant, these two types of transductants should occur at a low frequency, which would be dependent on the linkage of the two alleles and their location relative to his. On the other hand, if JC7623 carried only a single mutation affecting exonuclease I, neither of these types of transductants would be expected. Out of 4962 His+ transductants, none was obtained that was MitRUVRRec-or Mit8UV8Rec+. With the sbcB9 mutant JC7617, as a recipient, 2970 His+ transductants were screened and no MitRUVRRec-or MitsUVsRec+ transductants were found. These results indicate that in both cases the sbcB mutants carried no undetected xonA mutation.
DISCUSSION
We previously have shown that all sbcB-mutations result in loss of exonuclease I activity as measured by the degradation denatured DNA, presumably preferentially from a 3'OH end. We therefore concluded that the absence of this activity was directly responsible for the suppression of all the phenotypes associated with recB and recC mutations (4) . In other words, we hypothesized that the presence of exonuclease I activity prevented both recombination and repair of UV and mitomycin damage in the absence of the recB-recC enzyme. The findings presented here indicate that xonA mutations, which also lead to a disappearance of exonuclease I activity, can only effectively suppress the UV and Mit5 phenotypes.
There are several alternatives that explain the difference between the effects of xonA and sbcB mutations. The first explanation assumes that sbcB and xonA are synonyms for the same gene. Accordingly, sbcB mutations might destroy all exonuclease I activity while xonA mutations might leave a small amount of residual activity that is sufficient to prevent recombination, but low enough to permit repair of UV-and mitomycin-induced damage. The slight recovery of recombination proficiency by xonA mutants shown in Table 3 and the large proportion of MitR revertants from JC7645, which are the sbcB-variety, would fit this hypothesis. A direct enzymatic test is difficult because of the high residual levels of exonuclease activity on denatured DNA found in crude extracts of both sbcB and xonA mutants. As shown in Tables 2 and 3 , residual activity is 20-30% of wild-type levels. Preliminary studies on the purified residual activity from the sbcl5 strain, JC7689, with anti-exonuclease I serum indicate that this strain contains less than 1.5% of wild-type exonuclease I. A similar experiment must be done with a xonA mutant to determine if a higher residual amount of exonuclease I is present in such a strain.
A second, although, we feel, unlikely alternative holds that sbcB mutations are recessive control mutations preventing the synthesis of two products. One of these is exonuclease I and the other is an unknown product that is responsible for ingly, only xonA mutations would affect the structure of exonuclease I. A third explanation is that xonA and sbcB are two genes, both of which are essential for the 3'5' exonucleolytic activity of exonuclease I on single-stranded DNA, but one of which, sbcB, is required for an as yet unknown activity. According to this hypothesis it is the 3'-o.5' exonucleolytic activity on single-stranded DNA that prevents repair and the unknown activity that prevents recombination in the recBrecC-strain. If the sbcB subunit is mutant, both activities would be lost, and the recB-recC-strain would become UVR Rec+. A mutant xonA subunit, on the other hand, would eliminate only the 3'-*-5' exonucleolytic degradation, leaving the second activity unaltered; hence the recB-recC-strain would become UVR Rec-. A known enzyme that has properties somewhat analogous to these proposed for exonuclease I is tryptophan synthetase. The trpA subunit catalyzes the conversion of indole glycerol phosphate to indole, while the trpA and trpB subunits together catalyze the conversion of indole glycerol phosphate to tryptophan. It might also be possible that sbcB and xonA represent the same gene and that their polypeptide product possesses two types of activities. Complementation studies are now in progress to determine if xonA and sbcB are separate cistrons.
The appearance of phenotypically Rec-UVR MitR revertants from a Rec-UVSMitB parent suggests an enzymatic difference in the pathways for recombination and for repair of UV-and mitomycin-induced damage in the absence of the recB-recC enzyme combination. It appears that, in a recBrecC-strain, the presence of 3' -OH terminated singlestranded regions may be required for survival after UV irradiation and mitomycin treatment but not for recombination. 
